(PharmaNewsWire.Com, June 22, 2017 ) Gastro-Esophageal Reflux Disease (GERD) therapy isused to treat one of the most common & chronic gastric disease, GERD, that effects the quality of life of patients. GERD is the regurgitation of gastric contents into the esophagus. Since esophagus is not designed to tolerate the acidic contents of the stomach, the backflow causes damage to it. The treatment aims to eliminate the symptoms such as heartburn, acidic taste in mouth, hoarseness, dry cough, asthma etc & cure the disease. The disease, if not treated, may lead to strictures, ulcers & predisposes to cancerous conditions. The GERD therapy market comprises of an array of treatments consisting of medications, devices & surgery.
For more information about this report: http://www.reportsweb.com/global-gastro-esophageal-reflux-disease-drug-and-devices-market-analysis-and-forecast-2017-2023 The GERD therapy market is an already established market, in which a number of the drugs have lost patent protection. The market is driven by significant unmet medical need. The prospective growth is expected to be driven by favorable factors such as increased prevalence among world population, limited number of treatment options, need of new regulatory approved medication, and increase in the world geriatric population. Future market growth is particularly expected in Asia Pacific region where the prevalence of GERD therapy is increasing gradually. This research study includes an extensive analysis of the GERD therapy market by drug class, route of administration, dosage form, devices and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants. While highlighting the key driving and restraining forces for this established market, the report also provides a comprehensive section on competitive landscape, market share analysis, pipeline analysis, competitor benchmarking, and their positioning within the GERD therapy market. Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001840384/sample . The answers to the following key questions can be found in the report:-What are the major market drivers, challenges and opportunities of the global GERD therapy market?-How is the GERD therapy market evolving during the forecast period?-What are the driving and restraining factors in the GERD market?-What will be the market shares of drugs & devices of the global GERD therapy market by 2023?-How will each segment of the GERD therapy market grow over the forecast period and how much revenue will these account for in 2023?-How will the market share of the leading companies change in 2016 and which country will lead the market in 2017?-How will the industry evolve during the period between 2017 and 2023?-What are the key developmental strategies implemented in different applications across all regions?-Which geographical region will lead the global GERD therapymarket by the end of the forecast period?-What are the market trends and key developments in this market?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
